Citations

Mayo Clinic

Showing 10 of 108537 citations.

Author response: Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)
Zhang, Ting , Ambrodji, Alisa , Huang, Huixing, Etheridge, Amy S. , Schmidt, Remington E. , Bembenek, Brianna M. , Temesgen, Zoey B., Innocenti, Federico , Diasio, Robert B. , Largiadèr, Carlo R. , Offer, Steven M. , Largiadèr, Carlo R , Offer, Steven M , Bouchonville, Kelly J. , Wang, Zhiquan , Stroka, Deborah

No container title available | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.94075.3.sa2 Get It

Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)
Zhang, Ting , Ambrodji, Alisa , Huang, Huixing, Etheridge, Amy S. , Schmidt, Remington E. , Bembenek, Brianna M. , Temesgen, Zoey B., Innocenti, Federico , Diasio, Robert B. , Bouchonville, Kelly J. , Wang, Zhiquan , Stroka, Deborah , Largiadèr, Carlo R. , Offer, Steven M.

eLife | April 30, 2024 | Volume: 13 | Issue: No issue available | Pages: No page available

10.7554/elife.94075.3 Get It

Enhancers are critical for regulating tissue-specific gene expression, and genetic variants within enhancer regions have been suggested to contribute to various cancer-related processes, including therapeutic resistance. However, the precise mechanisms remain elusive. Using a well-defined drug-gene pair, we identified an enhancer region for dihydropyrimidine dehydrogenase (DPD, DPYD gene) expression that is relevant to the metabolism of the anti-cancer drug 5-fluorouracil (5-FU). Using reporter systems, CRISPR genome-edited cell models, and human liver specimens, we demonstrated in vitro and vivo that genotype status for the common germline variant (rs4294451; 27% global minor allele frequency) located within this novel enhancer controls DPYD transcription and alters resistance to 5-FU. The variant genotype increases recruitment of the transcription factor CEBPB to the enhancer and alters the level of direct interactions between the enhancer and DPYD promoter. Our data provide insight into the regulatory mechanisms controlling sensitivity and resistance to 5-FU.
Polypharmacy as Formal Training and a Model of Practice
Schuh, Michael J. , Crosby, Sheena , Crosby, Sheena K

The Senior Care Pharmacist | April 30, 2024 | Volume: 39 | Issue: 5 | Pages: 173-177

10.4140/tcp.n.2024.173 | PMID 38685622 Get It

Traditional definitions of polypharmacy may largely not account for the market proliferation of herbal and dietary supplements, cannabis products, or incorporate the new science of pharmacogenomics (PGx). Polypharmacy is encountered by most pharmacists providing patient care in many settings. The “polypharmacist” can assist patients and providers with solving medication-related problems (MRPs) in this new and challenging environment of supplements and cannabis products by utilizing traditional pharmacology and pharmacokinetic principles, including PGx, broadly across many medical disciplines. One may encounter polypharmacy more in the geriatric population, though in an age of supplements and cannabis proliferation, polypharmacy is increasingly being encountered at younger ages. Not only is polypharmacy training at best fragmented in pharmacy curricula, but it may also not account for the above-mentioned products that may use the same metabolic pathways to increase drug interactions and adverse drug reactions (ADRs) regarding prescription medications. Polypharmacy being more formally prioritized in pharmacist training may better prepare pharmacists for commonly encountered polypharmacy and can be a viable model of practice.
Characterization of Perioperative Serotonin in Patients Undergoing Orthotopic Liver Transplantation
Zott, Tobias , Kersten, Isabelle, Ortner, Max, Hüpper, Maria Noelle, Berlakovich, Gabriela , Silberhumer, Gerd R. , Berlakovich, Gabriela A , Silberhumer, Gerd R , Pereyra, David , Starlinger, Patrick

Journal of Clinical Medicine | April 30, 2024 | Volume: 13 | Issue: 9 | Pages: 2640

10.3390/jcm13092640 | PMID 38731169 Get It

Background: Platelets were shown to be relevant for liver regeneration. In particular, platelet-stored serotonin (5-HT) proved to be a pro-regenerative factor in this process. The present study aimed to investigate the perioperative course of 5-HT and evaluate associations with patient and graft outcomes after othotopic liver transplantation (OLT). Methods: 5-HT was quantified in plasma and serum of 44 OLT recipients perioperatively, and in their respective donors. Olthoff’s criteria for early allograft dysfunction (EAD) were used to evaluate postoperative outcomes. Results: Patients with higher donor intra-platelet 5-HT per platelet (IP 5-HT PP) values had significantly lower postoperative transaminases (ASAT POD1: p = 0.006, ASAT POD5: p = 0.006, ASAT POD10: p = 0.02, ALAT POD1: p = 0.034, ALAT POD5: p = 0.017, ALAT POD10: p = 0.04). No significant differences were seen between postoperative 5-HT values and the occurrence of EAD. A tendency was measured that donor IP 5-HT PP is lower in donor-recipient pairs that developed EAD (p = 0.07). Conclusions: Donor IP 5-HT PP might be linked to the postoperative development of EAD after OLT, as higher donor levels are correlated with a more favorable postoperative course of transaminases. Further studies with larger cohorts are needed to validate these findings.
A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer
Sridhar, Arthi , Khan, Hina, Yohannan, Binoy , Kataria, Nilansh, Jafri, Syed Hasan, Chan, Kok Hoe , Yohannan, Binoy , Chan, Kok Hoe

Journal of Clinical Medicine | April 30, 2024 | Volume: 13 | Issue: 9 | Pages: 2633

10.3390/jcm13092633 | PMID 38731161 Get It

The therapeutic landscape of the management of stage III non-small cell lung cancer (NSCLC) has drastically evolved with the incorporation of immunotherapy and targeted therapy. Stage III NSCLC accounts for one-third of the cases and the treatment strategy of these locally advanced presentations are diverse, ranging from surgical to non-surgical options; with the incorporation of chemo-immunotherapy, radiation, and targeted therapies wherever applicable. The staging of this disease has also changed, and it is essential to have a strong multidisciplinary approach to do justice to patient care. In this article, we aim to navigate the nuanced approaches in the diagnosis and treatment of stage III NSCLC and expand on the evolution of the management of this disease.
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
Kisiel, John B. , Fendrick, A. Mark , Ebner, Derek W. , Ozbay, A. Burak , Vahdat, Vahab , Estes, Chris , Limburg, Paul J. , Kisiel, John B , Ozbay, A Burak , Fendrick, A Mark , Limburg, Paul J , Vahdat, Vahab , Ebner, Derek

Journal of Medical Economics | April 30, 2024 | Volume: 27 | Issue: 1 | Pages: 746-753

10.1080/13696998.2024.2349467 | PMID 38686394 Get It

Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors
Chauhan, Aman, Chan, Kelley , Ge, Phillip S. , Anaya, Daniel A. , Bergsland, Emily K. , Mittra, Erik , Flem, Sherlonda, Brierley, James D. , Asare, Elliot A. , Washington, Kay, Shi, Chanjuan , Kendi, Ayse T, Asare, Elliot A , Shi, Chanjuan , Chauhan, Aman , Hálfdánarson, Þorvarður R. , Bellizzi, Andrew M. , Rindi, Guido , O’Toole, Dermot , Jain, Dhanpat , Dasari, Arvind , Wei, Alice C. , Hope, Thomas A. , Kendi, A. Tuba , Thomas, Samantha Marie

CA: A Cancer Journal for Clinicians | April 29, 2024 | Volume: 74 | Issue: 4 | Pages: 359-367

10.3322/caac.21840 | PMID 38685134 Get It

Abstract The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP‐NETs), is meant to be dynamic, requiring periodic updates to optimize AJCC staging definitions. This entails the collaboration of experts charged with evaluating new evidence that supports changes to each staging system. GEP‐NETs are the second most prevalent neoplasm of gastrointestinal origin after colorectal cancer. Since publication of the AJCC eighth edition, the World Health Organization has updated the classification and separates grade 3 GEP‐NETs from poorly differentiated neuroendocrine carcinoma. In addition, because of major advancements in diagnostic and therapeutic technologies for GEP‐NETs, AJCC version 9 advocates against the use of serum chromogranin A for the diagnosis and monitoring of GEP‐NETs. Furthermore, AJCC version 9 recognizes the increasing role of endoscopy and endoscopic resection in the diagnosis and management of NETs, particularly in the stomach, duodenum, and colorectum. Finally, T1NXM0 has been added to stage I in these disease sites as well as in the appendix.
AI and machine learning in medical imaging: key points from development to translation
Samala, Ravi K. , Chan, Heang‐Ping , Petrick, Nicholas , Mahmood, Usman , Summers, Ronald M. , Yoshida, Hiroyuki , Huo, Zhimin, Vergara, Daniel , Mazurchuk, Richard, Grizzard, Kevin , Suzuki, Kenji , Armato, Samuel G. , Shukla-Dave, Amita , Chan, Heang-Ping , Mahmood, Usman , Summers, Ronald M , Deserno, Thomas M , Yoshida, Hiroyuki , Drukker, Karen , Huisman, Henkjan , Samala, Ravi K , Drukker, Karen , Shukla‐Dave, Amita , Sahiner, Berkman , Greenspan, Hayit , Tourassi, Georgia D. , Regge, Daniele , Näppi, Janne J. , Chen, Quan , Morra, Lia , Hadjiiski, Lubomir M.

BJR|Artificial Intelligence | April 29, 2024 | Volume: 1 | Issue: 1 | Pages: No page available

10.1093/bjrai/ubae006 | PMID 38828430 Get It

Abstract Innovation in medical imaging artificial intelligence (AI)/machine learning (ML) demands extensive data collection, algorithmic advancements, and rigorous performance assessments encompassing aspects such as generalizability, uncertainty, bias, fairness, trustworthiness, and interpretability. Achieving widespread integration of AI/ML algorithms into diverse clinical tasks will demand a steadfast commitment to overcoming issues in model design, development, and performance assessment. The complexities of AI/ML clinical translation present substantial challenges, requiring engagement with relevant stakeholders, assessment of cost-effectiveness for user and patient benefit, timely dissemination of information relevant to robust functioning throughout the AI/ML lifecycle, consideration of regulatory compliance, and feedback loops for real-world performance evidence. This commentary addresses several hurdles for the development and adoption of AI/ML technologies in medical imaging. Comprehensive attention to these underlying and often subtle factors is critical not only for tackling the challenges but also for exploring novel opportunities for the advancement of AI in radiology.
Esophagogastroduodenoscopy Utilization and Inpatient Outcomes in Elderly Patients with Dementia: Socioeconomic Status Analysis of National Matched Cohorts
Suenghataiphorn, Thanathip , Thongpiya, Jerapas , Chaisidhivej, Natapat, Suenghataiphorn, Thanathip , Danpanichkul, Pojsakorn , Polpichai, Natchaya , Kulthamrongsri, Narathorn

No container title available | April 29, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4290535/v1 Get It

Abstract INTRODUCTION Esophagogastroduodenoscopy is safe and beneficial in elderly patients. However, the association of dementia, which is a growing cause of mortality in the elderly, remains unexplored. We aim to understand the impact of dementia when EGD is utilized, in the elderly population group. METHODS We utilized the 2020 National Inpatient Sample to investigate records admitted with EGD utilization identified through ICD-10 CM codes. We divided records by the presence of dementia. Adjusted odds ratios (aORs) for predefined outcomes were determined using multivariable logistic and linear regression models, adjusting for comorbidities. The primary outcome assessed was inpatient mortality, while secondary outcomes included cost and length of stay, as well as other inpatient complications. RESULTS We identified 507,829 hospitalizations with ages more than 60. The mean age was 74.5 and males constituted 49.9%. In a survey multivariable logistic and linear regression model adjusting for patient and hospital factors, the presence of dementia is associated with lower inpatient mortality (aOR 0.79, 95%CI (0.68, 0.91), p = 0.002), lower hospitalization costs (beta coefficient -1,958, 95%CI (-2,653, -1,353), p <0.001), lower mechanical ventilation usage (aOR 0.87, 95%CI(0.78, 0.97), p < 0.001) but higher odds of mental status change (aOR 2.24, 95%CI (2.09, 2.40), p < 0.001) and longer length of stay (beta coefficient 0.52, 95%CI (0.30, 0.74), p <0.001),. Post-propensity matching revealed similar patterns. CONCLUSION The presence of dementia is associated with a lower risk of inpatient mortality, and other clinical outcomes, in hospitalization with EGD utilizations. Etiologies behind this relationship should be explored to understand this inverse relationship.
RANDOMIZED TRIAL COMPARING MICROSERRATED VERSUS CONVENTIONAL INTERNAL LIMITING MEMBRANE FORCEPS FOR INTERNAL LIMITING MEMBRANE PEELING
Hinkle, John C. , Patel, Luv, Ammar, Michael J., Soares, Rebecca R. , Cohen, Michael N. , Hsu, Jason , Yonekawa, Yoshihiro , Regillo, Carl D. , Gupta, Omesh P. , Starr, Matthew R , Starr, Matthew R. , PATEL, SAMIR N. , Ho, Allen C.

Retina | April 29, 2024 | Volume: 44 | Issue: 8 | Pages: 1323-1328

10.1097/iae.0000000000004138 | PMID 39047125 Get It

Purpose: To evaluate anatomic outcomes and surgeon response following the use of microserrated (Sharkskin, Alcon, Forth Worth, TX) internal limiting membrane (ILM) forceps compared with conventional (Grieshaber; Alcon) ILM forceps for peeling of the ILM. Methods: Patients were prospectively assigned in a 1:1 randomized fashion to undergo ILM peeling using microserrated forceps or conventional forceps. Rates of retinal hemorrhages, deep retinal grasps, ILM regrasping, time to ILM removal, and surgeon questionnaire comparing the use of microserrated and conventional ILM forceps were analyzed. Results: A total of 90 eyes of 90 patients were included in this study. The mean number of deep retinal grasps was higher in the conventional forceps group (1.51 ± 1.70 vs. 0.33 ± 0.56, respectively [P < 0.0001]). The mean number of failed ILM grasps was higher with conventional forceps (6.62 ± 3.51 vs. 5.18 ± 2.06 [P = 0.019]). Microserrated forceps provided more comfortability (lower number) in initiating the ILM flap (2.16 ± 0.85 vs. 1.56 ± 0.76, P < 0.001), comfortability in regrasping the ILM flap (2.51 ± 1.01 vs. 1.98 ± 0.89, P = 0.01), and comfortability in completing the ILM flap (2.42 ± 1.03 vs. 1.84 ± 1.02, P = 0.01). Conclusion: Surgeons utilizing the microserrated forceps experienced fewer deep retina grasps and fewer failed ILM grasps compared with conventional ILM forceps. The microserrated forceps was also a more favorable experience subjectively among the surgeons.